Elegant Systems
Request Information

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research

Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk.  Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards.  Read this case study for lessons learned.

View In New Tab

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research published by Elegant Systems

We at Elegant Systems strive to live up to our name by delivering "Elegant Systems".

We strongly believe that IT can make a real difference to our customers’ businesses by Simplifying IT and reducing the Year on Year IT expense.

We are trusted by many small and medium size business including schools and charities across the globe. Our IT services and solutions has driven customer success.

We work closely with our technology partners to provide independent advice that helps our customers navigate the rapidly changing world of IT.

Our greatest strength is our underpinning value, which is to help Customer achieve Success by empowering everyone involved at all levels. Our attitude, "We are big enough to Dare and small enough to Care" means a lot to us, our customers, our partners and our vendors.